Lv1
2 积分 2024-11-07 加入
Combination therapy of avutometinib and MRTX1133 synergistically suppresses cell growth by inducing apoptosis in KRASG12D-mutated pancreatic cancer
8小时前
待确认
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
9小时前
已完结
Dual-payload ADCs move into first oncology clinical trials
1天前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
1天前
已完结
Enhanced prediction of antigen and antibody binding interface using ESM-2 and Bi-LSTM
5天前
已完结
Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer
13天前
已完结
Establishment of a BRAF V595E ‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer
14天前
已完结
MEK inhibitors in oncology: a patent review and update (2016 - present)
14天前
已完结
Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering
1个月前
已完结
Dectin-1 facilitates lung fungal-mediated pulmonary fibrosis
1个月前
已完结
皖公网安备34019202002308
